Stephen Lee is a Psychiatry physician. ClinicalTrials.gov lists 12 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
180 Fort Couch Rd
Suite 304
Pittsburgh, PA 152411041
Telephone
412-831-0355Registry record last updated 8 Jul 2007.
Clinical trials
- Evaluating Length and Depth Estimation Accuracy of Laypersons and Health-Care Providers
Sponsor: Seoul National University Hospital
- Evaluation of Effectiveness of Virtual Reality-based Dispatcher Assisted Cardiopulmonary Resuscitation Training
Sponsor: Seoul National University Hospital
- Evaluation of Efficacy of Online Real-time Home CPR Training Program
Sponsor: Seoul National University Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20222 payments
- AbbVie Inc.Program year20217 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.1%SSRI36.4%Fluoxetine Hcl53%Trazodone Hcl15%Sertraline Hcl13%Citalopram Hbr10%Escitalopram Oxalate9%Part D<11 patientsBenzodiazepine12.6%Lorazepam51%Clonazepam30%Temazepam19%Part D<11 patients+ 8 more classes in this area
Cardiovascular
5.9%Central alpha-2 Adrenergic Agonist3.8%Guanfacine Hcl Er100%Part D<11 patientsalpha-Adrenergic Blocker2.2%Prazosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2012–2012 per NIH RePORTER. The latest:
- Development of a rapid screening point-of-care test for HIV, HCV and HBV
Orasure Technologies, Inc.
FY2012$145,915R44AI096758
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”